Defendant Name: Aeon Global Health Corp.

Defendant Type: Public Company
SIC Code: 7372
CUSIP: 05266630

Initial Case Details

Legal Case Name In the Matter of Aeon Global Health Corp.
First Document Date 25-Sep-2020
Initial Filing Format Administrative Action
File Number 3-20073
Allegation Type Issuer Reporting and Disclosure
AAER 4171

Violations Alleged

Exchange Act
Sec 13(a)
Rule 13a-13
Rule 13a-15
Sec 13(b)(2)(A)
Sec 13(b)(2)(B)


First Resolution Date 25-Sep-2020

Related Documents:

34-90003 25-Sep-2020 Administrative Proceeding
Order Instituting Cease-and-Desist Proceedings Pursuant to Section 21C of the Securities Exchange Act of 1934, Making Findings, and Imposing a Cease-and-Desist Order
On September 25, 2020, the SEC instituted settled cease-and-desist proceedings against Aeon Global Health Corp. The Commission stated: "This proceeding involves violations of the federal securities laws in connection with the Respondent’s reporting, books and records, and internal accounting control failures, as well as its failure to maintain Internal Control over Financial Reporting (“ICFR”). Respondent failed to maintain, and did not remediate material weaknesses in, ICFR for fourteen consecutive reporting periods from the period ended March 31, 2016 through the period ended June 30, 2019. In addition, Respondent announced three financial statement restatements during the period from 2016 to 2019."
34-90003-s 25-Sep-2020 Administrative Summary
SEC Charges Healthcare Company with Standard Internal Control Failures
The SEC stated that: "[It] settled charges against Aeon Global Health Corp., a Georgia-based healthcare company, for failing to maintain internal control over financial reporting (ICFR)."